Page last updated: 2024-08-21

reticulin and Thrombocythemia

reticulin has been researched along with Thrombocythemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andraos, R; Baffert, F; Cozens, R; Dammassa, E; Dölemeyer, A; Ebel, N; Evrot, E; Hofmann, F; Murakami, M; Qian, Z; Radimerski, T; Roelli, C; Romanet, V; Sterker, D1
Lev, PR; Marta, RF; Molinas, FC; Vassallu, P1
Birgegård, G; Engström-Laurent, A; Hultdin, M; Lundström, B; Samuelsson, J; Sundström, G; Wahlin, A1
Choi, E; del Castillo, J; Hunt, P; Kaufman, S; Kinstler, O; Kirley, T; Senaldi, G; Sheridan, WP; Tarpley, J; Ulich, TR; Yin, S1
Brockschmidt, JK; Buss, DH; O'Connor, ML; Richards, F; Woodruff, RD1

Trials

2 trial(s) available for reticulin and Thrombocythemia

ArticleYear
Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide.
    American journal of hematology, 2002, Volume: 70, Issue:2

    Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Fibroblast Growth Factor 2; Fibrosis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet-Derived Growth Factor; Quinazolines; Reticulin; Thrombocytosis; Transforming Growth Factor beta

2002
Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
    Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fibrinolytic Agents; Humans; Hyaluronic Acid; Male; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Prospective Studies; Quinazolines; Reticulin; Thrombocythemia, Essential; Thrombocytosis

2007

Other Studies

3 other study(ies) available for reticulin and Thrombocythemia

ArticleYear
JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-15, Volume: 19, Issue:22

    Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Disease Models, Animal; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Indoles; Janus Kinase 1; Janus Kinase 2; Mice; Nitriles; Panobinostat; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reticulin; Spleen; Splenomegaly; STAT5 Transcription Factor; Thrombocytosis

2013
Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Anemia; Animals; Bone Marrow; Cell Count; Cell Differentiation; Hematopoietic Stem Cells; Humans; Hyperplasia; Injections, Intraperitoneal; Megakaryocytes; Mice; Mice, Inbred BALB C; Polyethylene Glycols; Primary Myelofibrosis; Recombinant Fusion Proteins; Recombinant Proteins; Reticulin; Splenomegaly; Thrombocytosis; Thrombopoietin

1996
Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases.
    Archives of pathology & laboratory medicine, 1991, Volume: 115, Issue:5

    Topics: Bone Marrow; Cell Aggregation; Humans; Iron; Megakaryocytes; Platelet Aggregation; Reticulin; Retrospective Studies; Thrombocytosis

1991